Efficacy and safety of piclidenoson in plaque psoriasis: Results from a randomized phase 3 clinical trial (COMFORT-1).
Kim A PappS Beyska-RizovaM L GantchevaE Slavcheva SimeonovaP BrezoevM CelicL GroppaT BlicharskiA SelmanagicM Kalicka-DudzikC A CalinN TrailovicM RamonA Bareket-SamishZ HarpazM FarbsteinM H SilvermanPnina Fishmannull nullPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Piclidenoson demonstrated efficacy responses that increased over time alongside a favourable safety profile. These findings support its continued clinical development as a psoriasis treatment (ClinicalTrials.gov identifier: NCT03168256).